Alexion Pharmaceuticals Aktie

154,32EUR
±0,00EUR
±0,00%
21.07.2021
182,50USD
+3,05USD
+1,70%
21.07.2021
Hier für 0 Euro handeln mit
Werbung
mehr Daten anzeigen

Alexion Pharmaceuticals Aktie Analyse

14.12.20 Alexion Pharmaceuticals Outperform RBC Capital Markets
07.08.18 Alexion Pharmaceuticals Hold Stifel, Nicolaus & Co., Inc.
18.12.17 Alexion Pharmaceuticals Outperform Robert W. Baird & Co. Incorporated
15.09.17 Alexion Pharmaceuticals Outperform RBC Capital Markets
13.09.17 Alexion Pharmaceuticals Buy Deutsche Bank AG
30.03.17 Alexion Pharmaceuticals Buy UBS AG
02.03.17 Alexion Pharmaceuticals Buy Instinet
17.02.17 Alexion Pharmaceuticals Outperform RBC Capital Markets
Werbung
22.12.16 Alexion Pharmaceuticals Outperform RBC Capital Markets
03.11.16 Alexion Pharmaceuticals Buy Deutsche Bank AG
28.10.16 Alexion Pharmaceuticals Neutral Wedbush Morgan Securities Inc.
28.10.16 Alexion Pharmaceuticals Mkt Perform FBR & Co.
23.09.16 Alexion Pharmaceuticals Neutral Wedbush Morgan Securities Inc.
15.09.16 Alexion Pharmaceuticals Underperform FBR & Co.
13.07.16 Alexion Pharmaceuticals buy SunTrust
13.07.16 Alexion Pharmaceuticals Outperform RBC Capital Markets
09.05.16 Alexion Pharmaceuticals Equal weight Barclays Capital
29.04.16 Alexion Pharmaceuticals Outperform BMO Capital Markets
08.04.16 Alexion Pharmaceuticals Market Perform BMO Capital Markets
08.03.16 Alexion Pharmaceuticals Neutral Robert W. Baird & Co. Incorporated
11.12.15 Alexion Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
14.09.15 Alexion Pharmaceuticals Equal weight Barclays Capital
31.07.15 Alexion Pharmaceuticals Buy UBS AG
31.07.15 Alexion Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
31.07.15 Alexion Pharmaceuticals Buy Brean Capital
07.05.15 Alexion Pharmaceuticals Buy Brean Capital
30.01.15 Alexion Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
08.01.15 Alexion Pharmaceuticals Buy UBS AG
25.10.12 Alexion Pharmaceuticals buy UBS AG
27.07.12 Alexion Pharmaceuticals buy Stifel, Nicolaus & Co., Inc.
26.07.12 Alexion Pharmaceuticals buy UBS AG
10.05.12 Alexion Pharmaceuticals overweight Barclays Capital
26.04.12 Alexion Pharmaceuticals overweight Barclays Capital
26.04.12 Alexion Pharmaceuticals hold Jefferies & Company Inc.
23.02.12 Alexion Pharmaceuticals buy UBS AG
13.02.12 Alexion Pharmaceuticals overweight Barclays Capital
10.02.12 Alexion Pharmaceuticals outperform Robert W. Baird & Co. Incorporated
24.01.12 Alexion Pharmaceuticals outperform Oppenheimer & Co. Inc.
30.12.11 Alexion Pharmaceuticals overweight Barclays Capital
29.12.11 Alexion Pharmaceuticals outperform Leerink Swann LLC
24.10.11 Alexion Pharmaceuticals hold Jefferies & Company Inc.
21.10.11 Alexion Pharmaceuticals neutral UBS AG
28.09.11 Alexion Pharmaceuticals buy Deutsche Bank Securities
27.09.11 Alexion Pharmaceuticals outperform Oppenheimer & Co. Inc.
25.07.11 Alexion Pharmaceuticals neutral UBS AG
11.07.11 Alexion Pharmaceuticals neutral UBS AG
08.07.11 Alexion Pharmaceuticals neutral UBS AG
18.05.11 Alexion Pharmaceuticals buy Goldman Sachs Group Inc.
26.04.11 Alexion Pharmaceuticals hold Needham & Company, LLC
25.03.11 Alexion Pharmaceuticals outperform Oppenheimer & Co. Inc.
Seite: 1 | 2 | 3

Analysensuche

GO
Werbung

Aktuelle News zu

finanzen.net Brokerage
finanzen.net Brokerage

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln